References
Managing depression in the primary care setting

Abstract
Depression affects more than 300 million people worldwide. The condition is thought to result from a complex interaction of social, biological and psychological factors. It is characterised by persistent low mood, and/or loss of pleasure in most activities over a 2-week period. Depression can be further categorised into mild, moderate and severe depression. In adults over the age of 65 years, depression tends to be as a result of comorbidities. There are various pharmacological and non-pharmacological treatments available for the condition. In the primary care setting, it is important to ensure that the patient is followed up regularly. Research into the various pharmacological treatment options is most welcome in improving care for patients suffering from depression.
It is estimated that depression is the third most common reason for GP consultations in the UK (National Institute for Health and Care Excellence (NICE), 2015). Statistics from 2014 reveal that there was a 1.5% increase from 2013 to 19.7% of patients over the age of 16 years in the UK suffering from either anxiety or depression (Mental Health Foundation, 2018). However, depression is often under-diagnosed and incorrectly treated (Smith et al, 2002). This article will explore the definition of depression, treatment options in adults and prescribing practice in primary care. The management of depression in children, adolescents and pregnant patients is beyond the remit of this article.
Depression is characterised by persistent low mood and/or loss of pleasure in most activities and a range of associated emotional, cognitive, physical, and behavioural symptoms (NICE, 2015). The DSM-5 diagnostic criteria requires the presence of at least five out of a possible nine symptoms (Table 1) over a 2-week period for a diagnosis to be made (American Psychiatric Association (APA), 2013). The symptoms must include persistent low mood and/or loss of interest or pleasure in all or almost all activities most days (APA, 2013). Other associated symptoms include weight loss/gain, appetite change, slowing down of thought or physical movement, fatigue, feeling of worthlessness, poor concentration and suicidal ideation (APA, 2013; Cleare et al, 2015; NICE, 2015; MacKinnon et al, 2019).
Register now to continue reading
Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:
What's included
-
Limited access to our clinical or professional articles
-
New content and clinical newsletter updates each month